3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
9
Unknown
3
Terminated
2
Recruiting
1
Not yet recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Neoplasm Metastasis
1
Lymphoma, B-Cell
1
Leukemia, Promyelocytic, Acute
1
Leukemia
1
Interventions
venetoclax
4
Cyclophosphamide
4
fludarabine
3
Azacitidine
3
blinatumomab
2
Whole-Body Irradiation
2
Cytarabine
2
Blood Specimen Collection
2
pegaspargase
1
etoposide phosphate
1
capivasertib
1
Vincristine
1
Tretinoin
1
Tissue Banks
1
Tacrolimus
1
Mycophenolic Acid
1
Methotrexate
1
Mercaptopurine
1
Immunotherapy, Adoptive
1
IPI-549
1
Etoposide
1
Drug Therapy, Combination
1
Doxorubicin
1
Dexamethasone
1
Decitabine
1
Calcium Dobesilate
1
Busulfan
1
Arsenic Trioxide
1
Anthracyclines
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Leukemia
×
Tretinoin
×
Clear all
NCT07296445
2025-12-29
LATITUDE
SDK Therapeutics, Inc.
Phase 3
Not yet recruiting
120 enrolled